⌘K

Home/Filings/4/0000950170-25-043893

4//SEC Filing

D'Onofrio Matthew J 4

Accession 0000950170-25-043893

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:30 PM ET

Size

4.5 KB

Accession

0000950170-25-043893

Insider Transaction Report

Form 4

Period: 2025-03-21

Evoke Pharma IncEVOK

D'Onofrio Matthew J

Exec VP, Chief Bus. Officer

Transactions

Award
Common Stock
2025-03-21$2.80/sh+1,000$2,797→ 9,820 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1

filerCIK 0001578770

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 4:30 PM ET
Size: 4.5 KB

View on SEC.gov